Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. (ανοίγει νέο παράθυρο)

Bourantas K, Makrydimas G, Georgiou J, Tsiara S, Lolis D.

Πηγή‎: Eur J Haematol 1996;56(5):326-8.

Καταχώριση‎: PubMed 8641410

https://www.ncbi.nlm.nih.gov/pubmed/8641410 (ανοίγει νέο παράθυρο)

On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease. (ανοίγει νέο παράθυρο)

el-Hazmi MA, al-Momen A, Kandaswamy S, Huraib S, Harakati M, al-Mohareb F, Warsy AS.

Πηγή‎: Acta Haematol 1995;94(3):128-34.

Καταχώριση‎: PubMed 7502628

https://www.ncbi.nlm.nih.gov/pubmed/7502628 (ανοίγει νέο παράθυρο)

Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review. (ανοίγει νέο παράθυρο)

Little JA, McGowan VR, Kato GJ, Partovi KS, Feld JJ, Maric I, Martyr S, Taylor JG 6th, Machado RF, Heller T, Castro O, Gladwin MT.

Πηγή‎: Haematologica 2006;91(8):1076-83.

Καταχώριση‎: PubMed 16885048

https://www.ncbi.nlm.nih.gov/pubmed/16885048 (ανοίγει νέο παράθυρο)

Use of erythropoietin in a pregnant Jehovah's Witness with sickle-cell disease. (ανοίγει νέο παράθυρο)

Tan TL, Ahmad H, Jhavar R, Patel R, Harrison C, Oteng-Ntim E.

Πηγή‎: J Obstet Gynaecol 2007;27(1):82-3.

Καταχώριση‎: PubMed 17365469

DOI‎: 10.1080/01443610601062739

https://www.ncbi.nlm.nih.gov/pubmed/17365469 (ανοίγει νέο παράθυρο)

The use of barbiturate coma as salvage therapy in a postoperative Jehovah's Witness patient with life-threatening anemia. (ανοίγει νέο παράθυρο)

Wang SW, Badami CD, Deitch EA.

Πηγή‎: Am Surg 2009;75(12):1175-8.

Καταχώριση‎: PubMed 19999907

https://www.ncbi.nlm.nih.gov/pubmed/19999907 (ανοίγει νέο παράθυρο)